US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.410
- -0.330-18.97%
Close Aug 23 16:00 ET
- 1.550
- +0.140+9.93%
Pre 04:22 ET
11.00MMarket Cap-810P/E (TTM)
1.736High1.400Low689.20KVolume1.680Open1.740Pre Close1.06MTurnover37.05%Turnover RatioLossP/E (Static)7.80MShares13.55852wk High-2.18P/B2.62MFloat Cap1.39052wk Low--Dividend TTM1.86MShs Float13.558Historical High--Div YieldTTM19.31%Amplitude1.390Historical Low1.537Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
CEOMr. Ilan Hadar
MarketNASDAQ
Address2 Ha'mayan Street
CityModiin
ProvinceJerusalem
CountryIsrael
Zip Code7177871
Phone972-8-628-6005
Websitehttps://www.silexion.com
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Prospective Chief Executive Officer
- 253.61K
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs and Prospective Chief Financial Officer
- 26.24K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 206.80K
- Ilan Levin
- Independent Director
- --
- Dror J. Abramov
- Independent Director
- --
- Avner Lushi
- Independent Director
- --
- Ruth Alon
- Independent Director
- --
- Shlomo Noy
- Independent Director
- --
- Ilan Shiloah
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg